ESC 365 - SHARE trial: P2Y12 Inhibitor Monotherapy vs DAPT After PCI

ESC Professional Premium Access

SHARE trial: P2Y12 Inhibitor Monotherapy vs DAPT After PCI

Session: Late-breaking science on acute coronary syndromes

Topic: Adjunctive Pharmacotherapy

Speaker: Professor P. Min (Seoul, KR)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Professor Pil-Ki Min

Gangnam Severance Hospital, Seoul (Korea (Republic of))

1 presentation

0 follower

4 more presentations in this session

Rosuvastatin versus atorvastatin treatment in LODESTAR trial

Speaker: Professor M. Hong (Seoul, KR)

BIOFLOW DAPT - Biodegradable polymer SES versus durable polymer ZES in HBR subjects with 1-month DAPT

Speaker: Professor M. Valgimigli (Lugano, CH)

The GUIDE-DES Trial - QCA versus IVUS guidance for DES implantation

Speaker: Professor S. Lee (Seoul, KR)

MRUSMI post-PCI - Post-PCI sonothrombolysis in STEMI patients with electrocardiographic no-reflow

Speaker: Mr S. El Kadi (Amsterdam, NL)

Access the full session

Late-breaking science on acute coronary syndromes

Speakers: Professor P. Min, Professor M. Hong, Professor M. Valgimigli, Professor S. Lee, Mr S. El Kadi

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources